Shock, Hemorrhagic
Information
- Disease name
- Shock, Hemorrhagic
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT01004198 | Completed | Phase 2 | Phase IIa Study of MP4OX in Traumatic Hemorrhagic Shock Patients | December 2009 | June 2010 |
| NCT01262196 | Completed | Phase 2 | Phase IIb Study of MP4OX in Traumatic Hemorrhagic Shock Patients | May 2011 | November 2012 |
| NCT02535624 | Completed | N/A | Retroperitoneal Packing or Angioembolization for Hemorrhage Control of Pelvic Fractures | February 2003 | February 2013 |
| NCT03218722 | Completed | Phase 3 | Early Administration of Prothrombin Concentrate Complex in Patients With Acute Hemorrhage Following Severe Trauma | December 29, 2017 | June 15, 2022 |
| NCT05953376 | Not yet recruiting | Phase 3 | Empiric Calcium in Massive Transfusion | January 2025 | December 2026 |
| NCT05638581 | Recruiting | Phase 3 | Trauma Resuscitation With Low-Titer Group O Whole Blood or Products | July 27, 2023 | June 30, 2027 |
| NCT04663087 | Terminated | N/A | Feasibility of Evaluating XSTAT Use in the Prehospital Setting | October 29, 2022 | August 11, 2023 |
| NCT03831022 | Unknown status | Usefulness of Capillary Refill Time and Skin Mottling Score to Predict Intensive Care Unit Admission | December 17, 2018 | December 17, 2020 | |
| NCT01780129 | Unknown status | Phase 2 | Polydatin Injectable (HW6) for Shock Treatment | February 2013 | December 2014 |
| NCT02303964 | Withdrawn | Phase 2/Phase 3 | Pre-Hospital Use of Plasma for Traumatic Hemorrhage | November 2014 | January 2016 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D012771